Maintaining standardization: An update of the HUPO Brain Proteome Project

Expert Review of Proteomics

Volumn 5, Issue 2, 2008, Pages 165-173

  Hamacher, Michael ^a   Stephan, Christian ^a   Eisenacher, Martin ^a   Hardt, Tanja ^a   Marcus, Katrin ^a   Meyer, Helmut E ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Alzheimer; Brain; Disease; HUPO; Neurodegeneration; Parkinson; Proteome

Indexed keywords

BIOLOGICAL MARKER; PROTEIN; PROTEOME;

AGING; ALZHEIMER DISEASE; BRAIN; DATA BASE; DEGENERATIVE DISEASE; DEMENTIA; GERMANY; KOREA; PARKINSON DISEASE; PROTEOMICS; REVIEW;

ANIMALS; BRAIN CHEMISTRY; DATA COLLECTION; HISTORY, 21ST CENTURY; HUMANS; PILOT PROJECTS; PROTEOME; PROTEOMICS; REFERENCE STANDARDS;

EID: 43449115426     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.5.2.165     Document Type: Review

References (16)

1. Evans DA, Funkenstein HH, Albert MS et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA 262, 2551-2556 (1989).
2. Ferri CP, Prince M, Brayne C et al. Alzheimer's Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112-2117 (2005).
3. Hallauer J. Home nursing of demented patients as an economic factor in public health. Krankenpfl. J. 42, 109-110 (2004).
4. Hamacher M, Meyer HE, Marcus K. New access to Alzheimer's and other neurodegenerative diseases. Expert Rev. Proteomics 4, 591-594 (2007).
5. Hamacher M, Meyer HE. HUPO Brain Proteome Project: aims and needs in proteomics. Expert Rev. Proteomics 2, 1-3 (2005).
6. Hamacher M, Apweiler R, Arnold G et al. HUPO Brain Proteome Project: summary of the pilot phase and introduction of a comprehensive data reprocessing strategy. Proteomics 6, 4890-4898 (2006). • Overview of the pilot studies of Human Proteome Organisation (HUPO) Brain Proteome Project, summarizing the groups involved, the strategies used and the results gained.
7. Klie S, Martens L, Vizcaíno JA et al. Analyzing large-scale proteomics projects with latent semantic indexing. J. Proteome Res. 7, 182-191 (2008). • Very interesting overview regarding the broad spectrum of instruments and methodologies applied in the HUPO Plasma Proteome Project, and recommendations for optimizing proteomics project as well as the choice of technologies.
8. Mueller M, Martens L, Apweiler R. Annotating the human proteome: beyond establishing a parts list. Biochim. Biophys. Acta. 1774, 175-191 (2006).
9. Martens L, Hermjakob H. Proteomics data validation: why all must provide data. Mol. Biosyst. 3, 518-522 (2007). • Appeal for providing data in a standardized way as one of the most important steps to guarantee comparability and reproducibility.
10. Mao L, Zabel C, Herrmann M et al. Proteomic shifts in embryonic stem cells with gene dose modifications suggest the presence of balancer proteins in protein regulatory networks. PLoS ONE. 2, E1218 (2007). • Introducing the balancer concept as an explanation why so many proteins show up in so many studies.
11. Zabel C. Proteins are specifically altered in disease - really? Expert Rev. Proteomics 3, 469-470 (2006).
12. Human Proteome Organisation www.hupo.org
13. The HUPO Proteomics Standards Initiative www.psidev.info
14. Proteomics Data Collection - ProDaC www.fp6-prodac.eu
15. PRIDE: PRoteomics IDEntifications database www.ebi.ac.uk/pride
16. HUPO Brain Proteome Project www.hbpp.org